Drug/Insect/Latex News

Food allergies were the most common of allergic conditions found in children with autism, according to findings recently published in JAMA Network Open.

Sanofi and Regeneron’s drug Dupixent led to clearer skin in most patients in phase 3 trial involving 12- to 17-year-olds with moderate-to-severe atopic dermatitis, according to a press release from the company.

The possible shortage of EpiPen and EpiPen Jr reported by NBC News and other mainstream media was worrisome but served as a reminder to plan ahead for food allergy-related emergencies, experts told Healio Family Medicine.

A laboratory test that used children’s plasma in cell activation to diagnose peanut allergy showed 98% specificity, according to recently published study results in The Journal of Allergy & Clinical Immunology.

Eosinophilic esophagitis has three distinct subtypes associated with different clinical features and molecular pathways, according to new research published in the Lancet Gastroenterology & Hepatology.

BOSTON — Rheumatologists, gastroenterologists, dermatologists, immunologists and other health care providers who care for patients with immune-mediated inflammatory diseases will gather at the Interdisciplinary Autoimmune Summit in Boston this weekend for a collaborative discussion of treatment strategies.

NEW ORLEANS — About 95% of patients currently labeled as penicillin allergic are not and most can be de-labeled through skin tests, John M. Kelso, MD, from the division of allergy, asthma and immunology at Scripps Clinic, told Healio Internal Medicine.

Sharp differences were found in how pediatricians and allergists managed peanut allergy in their patients, suggesting changes need to be made to how pediatricians provide such care, according to an abstract presented at the annual meeting of the American Academy of Allergy, Asthma & Immunology in Orlando.

Physician input may improve the care of asthma exacerbations and anaphylaxis in the school setting because emergency action plans are maintained by only approximately 41% of children with allergies and 21% of children with asthma, according to a study presented at the annual meeting of the American Academy of Allergy, Asthma & Immunology in Orlando.

Long-term and lower maintenance doses of peanut oral immunotherapy are an effective form of protection against peanut allergy for those with difficulties with standard oral immunotherapy, with nearly all patients succeeding with a 3,000 mg dose of peanut protein at follow-up, according to a study presented at the annual meeting of the American Academy of Allergy, Asthma & Immunology.